Legal: Page 3
-
Opinion
The importance of trust in AI as a medical device
Building trust with patients, as well as regulators, will be key to the adoption of AI in medical devices and diagnostics, argues Alison Dennis, a London-based partner with law firm Taylor Wessing.
By Alison Dennis • June 15, 2023 -
Teleflex prevails in Medtronic’s appeal over guide catheter patents
A federal appeals court judge denied Medtronic’s claims that Teleflex’s catheters were unpatentable.
By Elise Reuter • Updated June 7, 2023 -
Illumina appeals FTC’s order to divest Grail with plea for cancer screening test
The DNA-sequencing company that has been fighting regulators over orders to reverse its 2021 acquisition of Grail is accusing the U.S. government of overreach and collusion with European regulators.
By Susan Kelly • June 6, 2023 -
Precision Lens ordered to pay $487M for kickbacks to eye surgeons in Medicare false-claims case
Luxury vacations and tickets to Broadway shows were used by the Minnesota-based ophthalmologic supply company to induce surgeons to use its products, a federal court ruled.
By Elise Reuter • May 19, 2023 -
ITC to review ruling that Apple violated Masimo’s patents
If the ITC finds Apple improperly used Masimo’s pulse oximetry technology in the Apple Watch, the commission could ban imports of some Watch versions.
By Elise Reuter • May 17, 2023 -
Philips agrees to pay SEC more than $62M to settle China corruption charges
Resolving charges that employees, distributors and subsidiaries may have engaged in improper bidding in China lets Philips put the issue behind it without admitting guilt.
By Susan Kelly • May 12, 2023 -
Philips loses vote as shareholders push back against handling of respirator recall
The vote will allow investors to sue board members over their actions in 2022. Philips blamed the ballot loss on guidance from proxy advisors.
By Nick Paul Taylor • May 10, 2023 -
Masimo suit against Apple over smartwatch trade secrets ends in mistrial
The medical device maker said it intends to retry the lawsuit, as it awaits a decision from the International Trade Commission on a separate investigation into patent infringement claims against Apple.
By Susan Kelly • May 2, 2023 -
Lawsuit accuses J&J subsidiary of selling faulty knee replacements
A patient who had DePuy’s Attune knee system implanted, and then replaced when it loosened, claims the company downplayed the risks of the device.
By Elise Reuter • Updated April 21, 2023 -
Pear Therapeutics files for Chapter 11 bankruptcy
The maker of subscription apps for insomnia and substance abuse began exploring strategic alternatives earlier this month, and is still seeking a sale.
By Elise Reuter • April 7, 2023 -
Diagnostics execs charged with concealing lead test flaw
The former CEO and two other top executives of Magellan Diagnostics are accused of hiding a malfunction that caused tens of thousands of children and adults to receive inaccurately low lead test results.
By Susan Kelly • Updated April 5, 2023 -
Illumina ordered to divest Grail by FTC on anticompetition concerns
The San Diego-based DNA-sequencing company, which also faces a challenge from European antitrust regulators, said it will appeal the FTC’s order.
By Susan Kelly • April 3, 2023 -
Philips CEO Jakobs expects first settlement on respirators this year, Dutch newspaper says
Jakobs said he “hopes and expects” to reach a settlement with the Food and Drug Administration this year; settling suits over alleged medical damages may take longer.
By Peter Green • March 31, 2023 -
Medtech groups lose challenge to digital piracy rule in device repair case
Repair companies will still be able to access and use operating code to fix medical devices, after the court rejected arguments by AdvaMed and the Medical Imaging & Technology Alliance.
By Susan Kelly • March 13, 2023 -
Q&A
Friday Q&A: A regulatory attorney breaks down the EU MDR transition
Amsterdam-based regulatory expert Erik Vollebregt explains the agreement this week to extend the deadlines to comply with the EU’s Medical Device Regulation, and the issues that still need to be addressed.
By Susan Kelly • March 10, 2023 -
Ex-medtech CEO arrested over alleged scheme to sell dummy devices, defraud Medicare
Prosecutors accuse the former Stimwave CEO of engaging in a multi-year scheme to sell a device with no medical purpose for implantation into chronic pain patients.
By Nick Paul Taylor • March 10, 2023 -
AdvaMed calls Europe’s MDR extension a ‘strong step forward,’ but warns challenges remain
The extra time to certify medical devices in Europe is intended to prevent shortages, but the regulatory overhaul still poses problems for medtech firms, the U.S. lobbying group says.
By Susan Kelly • March 7, 2023 -
Medtech industry relieved as Europe’s MDR extension nears final approval
While the extra time to comply is aimed at preventing medical device shortages, the rules have still left some device makers and certifying bodies unclear about how to proceed, says one attorney.
By Susan Kelly • March 6, 2023 -
AliveCor says enforcement of Apple Watch import ban may take more than a year
The Biden administration upheld findings that Apple violated AliveCor’s patents, but a potential import ban rests on the outcome of a separate appeal, which could take several months.
By Elise Reuter • Feb. 22, 2023 -
J&J loses bid for Supreme Court review of $302M vaginal-mesh verdict
The justices’ decision to let a lower court verdict stand leaves the company subject to varying state liability laws, J&J says.
By Peter Green • Feb. 21, 2023 -
Applied Medical suit against Medtronic alleges surgical-device bundling practice curbs competition
Applied says in its filing that Medtronic “has conspired” to bundle devices for cutting tissue and sealing vessels “in a way that is unhealthy for competition.”
By Nick Paul Taylor • Updated Feb. 16, 2023 -
Alcon to pay J&J $199M to settle dispute over patents for laser eye surgery device
Alcon is settling the case for far less than the $3.1 billion that J&J’s damages expert argued the company could be owed.
By Nick Paul Taylor • Feb. 14, 2023 -
Medtronic ordered by jury to pay $106.5M to Colibri over TAVR patent infringement
Medtronic says the ruling will have no effect on its TAVR business as the patents expired last year and it vowed to appeal the verdict.
By Nick Paul Taylor • Updated Feb. 14, 2023 -
Invacare files for Chapter 11 bankruptcy protection amid supply chain woes
The wheelchair maker said it has reached a restructuring agreement with most of its debt holders and that demand for its products remains strong.
By Susan Kelly • Updated Feb. 3, 2023 -
FTC orders GoodRx to stop sharing users’ health data with advertisers, issues $1.5M fine
Regulators said they are putting the industry on watch with the enforcement against GoodRx, which allegedly collected data, including patient medications, and shared it without user consent.
By Rebecca Pifer • Updated Feb. 1, 2023